Safety and Effectiveness Study of BCI-540 Versus Placebo in the Treatment of Major Depressive Disorder With Concomitant Anxiety
This study has been completed.
Sponsor:
BrainCells Inc.
Information provided by (Responsible Party):
BrainCells Inc.
ClinicalTrials.gov Identifier:
NCT00621270
First received: February 11, 2008
Last updated: October 20, 2011
Last verified: October 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | October 2009 |
| Primary Completion Date: | October 2009 (Final data collection date for primary outcome measure) |